Patents by Inventor Rie Tajima

Rie Tajima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220278517
    Abstract: A fastening structure includes a fastening member including a bolt and a plurality of fastened members that are fastened and fixed to the fastening member. Further, the bolt contains pure aluminum or an aluminum alloy. At least one fastened member of the plurality of fastened members contains pure aluminum or an aluminum alloy. Pure aluminum or an aluminum alloy of a screw portion of the bolt is brought into direct contact with pure aluminum or an aluminum alloy of at least one fastened member.
    Type: Application
    Filed: February 24, 2022
    Publication date: September 1, 2022
    Applicant: Yazaki Corporation
    Inventors: Hayato IKEYA, Rie NAKABAYASHI, Kazushige TAJIMA, Satoru YOSHINAGA
  • Patent number: 8227578
    Abstract: The present invention provides an antibody specifically against hDlk-1 and having anti-tumor activity in vivo (an anti-hDlk-1 antibody), a fragment of the antibody, a hybridoma that produces the antibody, a complex of the antibody or antibody fragment and an agent, a pharmaceutical composition comprising the antibody and the like, a tumor therapeutic agent, a tumor angiogenesis inhibitor, a tumor diagnostic agent, a method for detecting a tumor, a kit for detecting and/or diagnosing a tumor, etc.
    Type: Grant
    Filed: November 12, 2007
    Date of Patent: July 24, 2012
    Assignee: Abe, Ikubo & Katayama
    Inventors: Koji Nakamura, Rie Tajima
  • Patent number: 8017118
    Abstract: The present invention provides antibodies specifically against hDlk-1 and having anti-tumor activity in vivo (anti-hDlk-1 antibodies), a fragments of the antibodies, hybridomas that produce the antibodies, a complex of the antibody or antibody fragment and an agent, a pharmaceutical composition comprising the antibody and the like, a tumor therapeutic agent, a tumor angiogenesis inhibitor, a tumor diagnostic agent, a method for detecting tumor, a kit for detecting and/or diagnosing tumor, etc.
    Type: Grant
    Filed: March 16, 2009
    Date of Patent: September 13, 2011
    Assignee: LivTech Inc. — Teikyo University Biotechnology Research Center
    Inventors: Koji Nakamura, Rie Tajima, Shankar Kumar, J. Yun Tso, Naoya Tsurushita
  • Publication number: 20090326205
    Abstract: The present invention provides an antibody specifically against hDlk-1 and having anti-tumor activity in vivo (an anti-hDlk-1 antibody), a fragment of the antibody, a hybridoma that produces the antibody, a complex of the antibody or antibody fragment and an agent, a pharmaceutical composition comprising the antibody and the like, a tumor therapeutic agent, a tumor angiogenesis inhibitor, a tumor diagnostic agent, a method for detecting a tumor, a kit for detecting and/or diagnosing a tumor, etc.
    Type: Application
    Filed: November 12, 2007
    Publication date: December 31, 2009
    Applicant: Liv Tech Inc.
    Inventors: Koji Nakamura, Rie Tajima
  • Publication number: 20090299038
    Abstract: The present invention provides antibodies specifically against hDlk-1 and having anti-tumor activity in vivo (anti-hDlk-1 antibodies), a fragments of the antibodies, hybridomas that produce the antibodies, a complex of the antibody or antibody fragment and an agent, a pharmaceutical composition comprising the antibody and the like, a tumor therapeutic agent, a tumor angiogenesis inhibitor, a tumor diagnostic agent, a method for detecting tumor, a kit for detecting and/or diagnosing tumor, etc.
    Type: Application
    Filed: March 16, 2009
    Publication date: December 3, 2009
    Applicant: LivTech Inc.
    Inventors: Koji Nakamura, Rie Tajima, Shankar Kumar, J. Yun Tso, Naoya Tsurushita
  • Publication number: 20070128328
    Abstract: An object of the invention is to provide a bacterial growth inhibitor or bacteriostatic agent against thermo-resistant and acid-resistant bacteria (TAB: thermo acidophillic bacilli), such as bacteria belonging to the genus Alicyclobacillus, in particular, guaiacol-producible Alicyclobacillus acidoterrestris, Alicyclobacillus acidiphilus, and Alicyclobacillus herbarium, the bacterial growth inhibitor or bacteriostatic agent being derived from naturally occurring substances and facile in procurement, preparation, and handling. The invention provides a bacterial growth inhibitor or bacteriostatic agent against bacteria belonging to the genus Alicyclobacillus, which contains acerola fruit juice as an active ingredient.
    Type: Application
    Filed: December 10, 2004
    Publication date: June 7, 2007
    Inventors: Shozo Tanada, Rie Tajima, Takeshi Koizumi, Satoshi Yamamoto, Hitoshi Aoki, Takayuki Hanamura, Chisato Mayama